| Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of … N Galiè, MM Hoeper, M Humbert, A Torbicki, JL Vachiery, JA Barbera, ... European heart journal 30 (20), 2493-2537, 2009 | 6017 | 2009 |
| Bosentan therapy for pulmonary arterial hypertension LJ Rubin, DB Badesch, RJ Barst, N Galie, CM Black, A Keogh, T Pulido, ... New England Journal of Medicine 346 (12), 896-903, 2002 | 3746 | 2002 |
| ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the … Writing Committee Members, VV McLaughlin, SL Archer, DB Badesch, ... Circulation 119 (16), 2250-2294, 2009 | 3487 | 2009 |
| A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension RJ Barst, LJ Rubin, WA Long, MD McGoon, S Rich, DB Badesch, ... New England Journal of Medicine 334 (5), 296-301, 1996 | 3478 | 1996 |
| Sildenafil citrate therapy for pulmonary arterial hypertension N Galiè, HA Ghofrani, A Torbicki, RJ Barst, LJ Rubin, D Badesch, ... New England Journal of Medicine 353 (20), 2148-2157, 2005 | 3364 | 2005 |
| Clinical classification of pulmonary hypertension G Simonneau, N Galiè, LJ Rubin, D Langleben, W Seeger, ... Journal of the American College of Cardiology 43 (12S), S5-S12, 2004 | 2835 | 2004 |
| Inhaled iloprost for severe pulmonary hypertension H Olschewski, G Simonneau, N Galiè, T Higenbottam, R Naeije, LJ Rubin, ... New England Journal of Medicine 347 (5), 322-329, 2002 | 2467 | 2002 |
| Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study RN Channick, G Simonneau, O Sitbon, IM Robbins, A Frost, VF Tapson, ... The Lancet 358 (9288), 1119-1123, 2001 | 2103 | 2001 |
| Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial G Simonneau, RJ Barst, N Galie, R Naeije, S Rich, RC Bourge, A Keogh, ... American journal of respiratory and critical care medicine 165 (6), 800-804, 2002 | 1914 | 2002 |
| Primary pulmonary hypertension LJ Rubin New England Journal of Medicine 336 (2), 111-117, 1997 | 1855 | 1997 |
| Macitentan and morbidity and mortality in pulmonary arterial hypertension T Pulido, I Adzerikho, RN Channick, M Delcroix, N Galiè, HA Ghofrani, ... New England Journal of Medicine 369 (9), 809-818, 2013 | 1715 | 2013 |
| Riociguat for the treatment of pulmonary arterial hypertension HA Ghofrani, N Galiè, F Grimminger, E Grünig, M Humbert, ZC Jing, ... New England Journal of Medicine 369 (4), 330-340, 2013 | 1642 | 2013 |
| Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society … N Galie, A Torbicki, R Barst, P Dartevelle, S Haworth, T Higenbottam, ... European heart journal 25 (24), 2243-2278, 2004 | 1573 | 2004 |
| Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure NF Voelkel, RA Quaife, LA Leinwand, RJ Barst, MD McGoon, ... Circulation 114 (17), 1883-1891, 2006 | 1528 | 2006 |
| Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial DB Badesch, VF Tapson, MD McGoon, BH Brundage, LJ Rubin, ... Annals of internal medicine 132 (6), 425-434, 2000 | 1497 | 2000 |
| Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial N Galiè, LJ Rubin, MM Hoeper, P Jansa, H Al-Hiti, GMB Meyer, E Chiossi, ... The Lancet 371 (9630), 2093-2100, 2008 | 1332 | 2008 |
| Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled … N Galiè, H Olschewski, RJ Oudiz, F Torres, A Frost, HA Ghofrani, ... Circulation 117 (23), 3010-3019, 2008 | 1311 | 2008 |
| Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension N Galiè, JA Barberà, AE Frost, HA Ghofrani, MM Hoeper, VV McLaughlin, ... New England Journal of Medicine 373 (9), 834-844, 2015 | 1283 | 2015 |
| Selexipag for the treatment of pulmonary arterial hypertension O Sitbon, R Channick, KM Chin, A Frey, S Gaine, N Galiè, HA Ghofrani, ... New England Journal of Medicine 373 (26), 2522-2533, 2015 | 1142 | 2015 |
| Chronic thromboembolic pulmonary hypertension PF Fedullo, WR Auger, KM Kerr, LJ Rubin New England Journal of Medicine 345 (20), 1465-1472, 2001 | 1078 | 2001 |
